US EditionJeff Ervin joins Allarity as CFO - BioTuesdays
Summary by biotuesdays.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Jeff Ervin joins Allarity as CFO - BioTuesdays
Allarity Therapeutics (NASDAQ: ALLR) has announced the appointment of Jeff Ervin as chief financial officer (CFO), succeeding Alexander Epshinsky, who will remain involved during the transition period. Mr. Ervin brings nearly two decades of executive leadership experience across healthcare, biotech, and other sectors to the role. Most recently, he served as co-chief financial officer at DayDayCook (NYSEM: DDC). He holds an MBA in Finance and Str…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
